+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dengue Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 240 Pages
  • May 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5972667
The global incidence of dengue has been increasing rapidly, with significant impacts in major regions including Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. The World Health Organization (WHO) reports a continuous rise in the number of dengue cases, highlighting the urgent need for effective diagnostic solutions.

Rising Dengue Cases Across the Globe

Americas

In the Americas, the prevalence of dengue has reached alarming levels, with millions of reported cases. Brazil has emerged as a hotspot, contributing a substantial portion of these cases. The surge in dengue cases in Brazil is approximately three times higher than previously reported figures, underscoring the growing health crisis.

Western Pacific Region

The Western Pacific region has also witnessed a significant number of suspected dengue cases. The Philippines and Malaysia are among the most affected countries, with both reporting a high number of cases. This escalating prevalence of dengue virus in these regions is driving the demand for diagnostic kits, which are crucial for timely and accurate detection.

Climate Change and Dengue Fever

Impact of Climate Change

Climate change is exacerbating the prevalence of dengue fever worldwide. Recent outbreaks of dengue, chikungunya, and West Nile virus in previously unaffected countries highlight the potential threats posed by global warming. Changes in climate have heightened the current and future risks in various regions, including Europe. Altered climatic conditions have significantly impacted vector distribution and potential disease transmission.

Environmental Factors

Environmental factors such as high rainfall and humidity create favorable breeding conditions for mosquitoes. Additionally, curtailed water supply and disrupted sanitation services facilitate mosquito proliferation, while warm temperatures extend the active season for these vectors. These climatic changes are likely to increase the burden of dengue fever, subsequently driving the growth of the dengue testing market.

Innovations in Dengue Testing

Need for Cost-Effective Diagnostic Kits

Currently, the available diagnostic test kits for dengue are less effective, creating a need for cost-effective kits with high specificity and sensitivity. The high price and limited effectiveness of existing test kits have prompted companies to focus on developing reliable and affordable diagnostic methods. Increasing research and development activities aim to produce highly specific and sensitive diagnostic kits, opening new growth opportunities for manufacturers.

Development of Point-of-Care Tests

Manufacturers are prioritizing the development of point-of-care tests that are rapid, sensitive, and easy to use. Many existing methods for detecting dengue virus rely on cell culture and mice inoculation, which are slow and expensive. There is a pressing need for rapid, user-friendly, and sensitive detection methods to enhance the efficiency of dengue diagnosis.

Global Dengue Testing Market by Region

Dominance of Asia Pacific

The Asia Pacific region has been at the forefront of the global dengue testing market in terms of revenue. This trend is expected to continue, with Asia Pacific projected to remain the most attractive market for dengue testing. The region's significant share in the global dengue testing market underscores its critical role in addressing the dengue epidemic.

Key Market Players Include:

  • Abnova Corporation
  • Roche Molecular Systems Inc.
  • Abbott Laboratories
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Euroimmun AG (Sub. PerkinElmer)
  • Quest Diagnostics
  • Certest Biotec S.L.
  • OriGene Technologies
  • Thermo Fisher Scientific Inc.
  • Others.

Global Dengue Testing Market Segmentation:

By Product Type:

  • Premium
  • Mid
  • Low

By End User:

  • Hospitals
  • Public Health Laboratory
  • Diagnostic Centers
  • Others

By Region:

  • China
  • India
  • Japan
  • Indonesia
  • South Korea
  • Rest of Asia Pacific


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Dengue Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Economic Overview
2.6.1. World Economic Projections
2.7. PESTLE Analysis
3. Global Dengue Testing Market Outlook, 2018 - 2031
3.1. Global Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. ELISA-based Tests
3.1.1.2. RT-PCR based Tests
3.1.1.3. Dengue IgG/IgM Rapid Test
3.2. Global Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Public Health Laboratory
3.2.1.3. Diagnostic Centers
3.2.1.4. Others
3.3. Global Dengue Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Dengue Testing Market Outlook, 2018 - 2031
4.1. North America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. ELISA-based Tests
4.1.1.2. RT-PCR based Tests
4.1.1.3. Dengue IgG/IgM Rapid Test
4.2. North America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Public Health Laboratory
4.2.1.3. Diagnostic Centers
4.2.1.4. Others
4.3. North America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Dengue Testing Market Outlook, 2018 - 2031
5.1. Europe Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. ELISA-based Tests
5.1.1.2. RT-PCR based Tests
5.1.1.3. Dengue IgG/IgM Rapid Test
5.2. Europe Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Public Health Laboratory
5.2.1.3. Diagnostic Centers
5.2.1.4. Others
5.3. Europe Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Dengue Testing Market by Product Type, Value (US$Bn), 2018 - 2031
5.3.1.14. Rest of Europe Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Dengue Testing Market Outlook, 2018 - 2031
6.1. Asia Pacific Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. ELISA-based Tests
6.1.1.2. RT-PCR based Tests
6.1.1.3. Dengue IgG/IgM Rapid Test
6.2. Asia Pacific Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Public Health Laboratory
6.2.1.3. Diagnostic Centers
6.2.1.4. Others
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Dengue Testing Market Outlook, 2018 - 2031
7.1. Latin America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. ELISA-based Tests
7.1.1.2. RT-PCR based Tests
7.1.1.3. Dengue IgG/IgM Rapid Test
7.2. Latin America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hospitals
7.2.1.2. Public Health Laboratory
7.2.1.3. Diagnostic Centers
7.2.1.4. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Dengue Testing Market Outlook, 2018 - 2031
8.1. Middle East & Africa Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. ELISA-based Tests
8.1.1.2. RT-PCR based Tests
8.1.1.3. Dengue IgG/IgM Rapid Test
8.2. Middle East & Africa Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Public Health Laboratory
8.2.1.3. Diagnostic Centers
8.2.1.4. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company Overview
9.4.1.2. Therapy Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Roche Molecular Systems Inc.
9.4.2.1. Company Overview
9.4.2.2. Therapy Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Abbott Laboratories
9.4.3.1. Company Overview
9.4.3.2. Therapy Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. InBios International, Inc.
9.4.4.1. Company Overview
9.4.4.2. Therapy Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. NovaTec Immundiagnostica GmbH
9.4.5.1. Company Overview
9.4.5.2. Therapy Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Quest Diagnostics
9.4.6.1. Company Overview
9.4.6.2. Therapy Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Certest Biotec S.L.
9.4.7.1. Company Overview
9.4.7.2. Therapy Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. OriGene Technologies
9.4.8.1. Company Overview
9.4.8.2. Therapy Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Abnova Corporation
9.4.9.1. Company Overview
9.4.9.2. Therapy Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Others
9.4.10.1. Company Overview
9.4.10.2. Therapy Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abnova Corporation
  • Roche Molecular Systems Inc.
  • Abbott Laboratories
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Euroimmun AG (Sub. PerkinElmer)
  • Quest Diagnostics
  • Certest Biotec S.L.
  • OriGene Technologies
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...